0001493152-22-017153.txt : 20220617 0001493152-22-017153.hdr.sgml : 20220617 20220617160544 ACCESSION NUMBER: 0001493152-22-017153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220616 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Cheryl CENTRAL INDEX KEY: 0001529371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 221023771 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 201 SPEAR ST., 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2022-06-16 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001529371 Cohen Cheryl C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 1 0 0 0 Non-Qualified Stock Option (right to buy) 22.48 2022-06-16 4 A 0 27200 0.00 A 2032-06-16 Common Stock 27200 27200 D Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. One third vests on the first, second and third anniversaries of the date of grant. /s/ Sam Martin, attorney-in-fact for Cheryl L. Cohen 2022-06-17